Founded in 1999, its success has been swift and emphatic, and it is an industry leader in online pharmaceuticals. Here are some of the reasons it has enjoyed success in the last few years.
New Chairman
The arrival of Andy Hornby as chairman of the company in 2012 has undoubtedly contributed towards the most recent successes of Pharmacy2U. He has experience in many areas of the business world, having been a boss at both HBOS and Alliance Boots.
Since his arrival, Pharmacy2U has made a number of big business moves which have served to promote growth and stimulate even more success. With his expertise in the pharmaceutical industry as well as other industries, there is no doubt that the company will continue to be steered in a progressive and profitable direction.
ChemistDirect
One of the major developments for the company in recent years was its merging with ChemistDirect in a deal worth £40m. It was also backed by a £10m investment from the Business Growth Fund and meant that they would be serving 1.5 million customers in the UK.
The deal was undoubtedly a landmark in the company’s history and has paved the way for major successes further down the line. With the power of two companies combined instead of one, it is hard to see how anything could stop Pharmacy2U from dominating the market anytime soon.
£7m Funding
The Business Growth Fund has also provided £7m of funding for the company this year. This will help them build on their previous funding and boost business growth through investments in TV, press, online and radio advertising.
With this in mind, it is likely that the customer base for the company will continue to grow as more people become aware of the innovative and effective service Pharmacy2U offers. If this is the case, then the company will undoubtedly continue to grow at a rapid pace, and potentially have the power to buy its competitors out.
The journey of Pharmacy2U as a business has been remarkable, and it has certainly set the precedent for online pharmaceutical companies. Having supplied GPs and other NHS institutions for nearly 20 years, and showing no signs of stopping, the company is sure to have a bright future ahead of it.
